Report Detail

Pharma & Healthcare Global Measles Vaccine Market Insights and Forecast to 2026

  • RnM4137143
  • |
  • 14 August, 2020
  • |
  • Global
  • |
  • 112 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Measles Vaccine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Measles Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Measles Vaccine market is segmented into
Mumps Measles Rubella Vaccine, Live (MMR-II)
Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)

Segment by Application, the Measles Vaccine market is segmented into
Children
Adults

Regional and Country-level Analysis
The Measles Vaccine market is analysed and market size information is provided by regions (countries).
The key regions covered in the Measles Vaccine market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Measles Vaccine Market Share Analysis
Measles Vaccine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Measles Vaccine business, the date to enter into the Measles Vaccine market, Measles Vaccine product introduction, recent developments, etc.

The major vendors covered:
GSK
Sanofi-Pasteur
Merck
Novartis
Pfizer
Serum Institute of India
China National Biotech Group
Bavarian Nordic
Emergent Biosolutions
Medimmune
Johnson & Johnson
CSL Limited


1 Study Coverage

  • 1.1 Measles Vaccine Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Measles Vaccine Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Measles Vaccine Market Size Growth Rate by Type
    • 1.4.2 Mumps Measles Rubella Vaccine, Live (MMR-II)
    • 1.4.3 Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)
  • 1.5 Market by Application
    • 1.5.1 Global Measles Vaccine Market Size Growth Rate by Application
    • 1.5.2 Children
    • 1.5.3 Adults
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Measles Vaccine Market Size, Estimates and Forecasts
    • 2.1.1 Global Measles Vaccine Revenue 2015-2026
    • 2.1.2 Global Measles Vaccine Sales 2015-2026
  • 2.2 Global Measles Vaccine, Market Size by Producing Regions: 2015 VS 2020 VS 2026
    • 2.2.1 Global Measles Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Measles Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Measles Vaccine Competitor Landscape by Players

  • 3.1 Measles Vaccine Sales by Manufacturers
    • 3.1.1 Measles Vaccine Sales by Manufacturers (2015-2020)
    • 3.1.2 Measles Vaccine Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Measles Vaccine Revenue by Manufacturers
    • 3.2.1 Measles Vaccine Revenue by Manufacturers (2015-2020)
    • 3.2.2 Measles Vaccine Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Measles Vaccine Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Measles Vaccine Revenue in 2019
    • 3.2.5 Global Measles Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Measles Vaccine Price by Manufacturers
  • 3.4 Measles Vaccine Manufacturing Base Distribution, Product Types
    • 3.4.1 Measles Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Measles Vaccine Product Type
    • 3.4.3 Date of International Manufacturers Enter into Measles Vaccine Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Measles Vaccine Market Size by Type (2015-2020)
    • 4.1.1 Global Measles Vaccine Sales by Type (2015-2020)
    • 4.1.2 Global Measles Vaccine Revenue by Type (2015-2020)
    • 4.1.3 Measles Vaccine Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Measles Vaccine Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Measles Vaccine Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Measles Vaccine Revenue Forecast by Type (2021-2026)
    • 4.2.3 Measles Vaccine Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Measles Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Measles Vaccine Market Size by Application (2015-2020)
    • 5.1.1 Global Measles Vaccine Sales by Application (2015-2020)
    • 5.1.2 Global Measles Vaccine Revenue by Application (2015-2020)
    • 5.1.3 Measles Vaccine Price by Application (2015-2020)
  • 5.2 Measles Vaccine Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Measles Vaccine Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Measles Vaccine Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Measles Vaccine Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Measles Vaccine by Country
    • 6.1.1 North America Measles Vaccine Sales by Country
    • 6.1.2 North America Measles Vaccine Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Measles Vaccine Market Facts & Figures by Type
  • 6.3 North America Measles Vaccine Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Measles Vaccine by Country
    • 7.1.1 Europe Measles Vaccine Sales by Country
    • 7.1.2 Europe Measles Vaccine Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Measles Vaccine Market Facts & Figures by Type
  • 7.3 Europe Measles Vaccine Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Measles Vaccine by Region
    • 8.1.1 Asia Pacific Measles Vaccine Sales by Region
    • 8.1.2 Asia Pacific Measles Vaccine Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Measles Vaccine Market Facts & Figures by Type
  • 8.3 Asia Pacific Measles Vaccine Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Measles Vaccine by Country
    • 9.1.1 Latin America Measles Vaccine Sales by Country
    • 9.1.2 Latin America Measles Vaccine Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Measles Vaccine Market Facts & Figures by Type
  • 9.3 Central & South America Measles Vaccine Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Measles Vaccine by Country
    • 10.1.1 Middle East and Africa Measles Vaccine Sales by Country
    • 10.1.2 Middle East and Africa Measles Vaccine Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Measles Vaccine Market Facts & Figures by Type
  • 10.3 Middle East and Africa Measles Vaccine Market Facts & Figures by Application

11 Company Profiles

  • 11.1 GSK
    • 11.1.1 GSK Corporation Information
    • 11.1.2 GSK Description and Business Overview
    • 11.1.3 GSK Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 GSK Measles Vaccine Products Offered
    • 11.1.5 GSK Related Developments
  • 11.2 Sanofi-Pasteur
    • 11.2.1 Sanofi-Pasteur Corporation Information
    • 11.2.2 Sanofi-Pasteur Description and Business Overview
    • 11.2.3 Sanofi-Pasteur Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Sanofi-Pasteur Measles Vaccine Products Offered
    • 11.2.5 Sanofi-Pasteur Related Developments
  • 11.3 Merck
    • 11.3.1 Merck Corporation Information
    • 11.3.2 Merck Description and Business Overview
    • 11.3.3 Merck Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Merck Measles Vaccine Products Offered
    • 11.3.5 Merck Related Developments
  • 11.4 Novartis
    • 11.4.1 Novartis Corporation Information
    • 11.4.2 Novartis Description and Business Overview
    • 11.4.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Novartis Measles Vaccine Products Offered
    • 11.4.5 Novartis Related Developments
  • 11.5 Pfizer
    • 11.5.1 Pfizer Corporation Information
    • 11.5.2 Pfizer Description and Business Overview
    • 11.5.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Pfizer Measles Vaccine Products Offered
    • 11.5.5 Pfizer Related Developments
  • 11.6 Serum Institute of India
    • 11.6.1 Serum Institute of India Corporation Information
    • 11.6.2 Serum Institute of India Description and Business Overview
    • 11.6.3 Serum Institute of India Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Serum Institute of India Measles Vaccine Products Offered
    • 11.6.5 Serum Institute of India Related Developments
  • 11.7 China National Biotech Group
    • 11.7.1 China National Biotech Group Corporation Information
    • 11.7.2 China National Biotech Group Description and Business Overview
    • 11.7.3 China National Biotech Group Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 China National Biotech Group Measles Vaccine Products Offered
    • 11.7.5 China National Biotech Group Related Developments
  • 11.8 Bavarian Nordic
    • 11.8.1 Bavarian Nordic Corporation Information
    • 11.8.2 Bavarian Nordic Description and Business Overview
    • 11.8.3 Bavarian Nordic Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 Bavarian Nordic Measles Vaccine Products Offered
    • 11.8.5 Bavarian Nordic Related Developments
  • 11.9 Emergent Biosolutions
    • 11.9.1 Emergent Biosolutions Corporation Information
    • 11.9.2 Emergent Biosolutions Description and Business Overview
    • 11.9.3 Emergent Biosolutions Sales, Revenue and Gross Margin (2015-2020)
    • 11.9.4 Emergent Biosolutions Measles Vaccine Products Offered
    • 11.9.5 Emergent Biosolutions Related Developments
  • 11.10 Medimmune
    • 11.10.1 Medimmune Corporation Information
    • 11.10.2 Medimmune Description and Business Overview
    • 11.10.3 Medimmune Sales, Revenue and Gross Margin (2015-2020)
    • 11.10.4 Medimmune Measles Vaccine Products Offered
    • 11.10.5 Medimmune Related Developments
  • 11.1 GSK
    • 11.1.1 GSK Corporation Information
    • 11.1.2 GSK Description and Business Overview
    • 11.1.3 GSK Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 GSK Measles Vaccine Products Offered
    • 11.1.5 GSK Related Developments
  • 11.12 CSL Limited
    • 11.12.1 CSL Limited Corporation Information
    • 11.12.2 CSL Limited Description and Business Overview
    • 11.12.3 CSL Limited Sales, Revenue and Gross Margin (2015-2020)
    • 11.12.4 CSL Limited Products Offered
    • 11.12.5 CSL Limited Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Measles Vaccine Market Estimates and Projections by Region
    • 12.1.1 Global Measles Vaccine Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Measles Vaccine Revenue Forecast by Regions 2021-2026
  • 12.2 North America Measles Vaccine Market Size Forecast (2021-2026)
    • 12.2.1 North America: Measles Vaccine Sales Forecast (2021-2026)
    • 12.2.2 North America: Measles Vaccine Revenue Forecast (2021-2026)
    • 12.2.3 North America: Measles Vaccine Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Measles Vaccine Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Measles Vaccine Sales Forecast (2021-2026)
    • 12.3.2 Europe: Measles Vaccine Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Measles Vaccine Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Measles Vaccine Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Measles Vaccine Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Measles Vaccine Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Measles Vaccine Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Measles Vaccine Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Measles Vaccine Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Measles Vaccine Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Measles Vaccine Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Measles Vaccine Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Measles Vaccine Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Measles Vaccine Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Measles Vaccine Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter's Five Forces Analysis
  • 13.5 Primary Interviews with Key Measles Vaccine Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Measles Vaccine Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Summary:
    Get latest Market Research Reports on Measles Vaccine. Industry analysis & Market Report on Measles Vaccine is a syndicated market report, published as Global Measles Vaccine Market Insights and Forecast to 2026. It is complete Research Study and Industry Analysis of Measles Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,900.00
    $5,850.00
    $7,800.00
    3,084.90
    4,627.35
    6,169.80
    3,595.80
    5,393.70
    7,191.60
    605,670.00
    908,505.00
    1,211,340.00
    325,650.00
    488,475.00
    651,300.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report